Restoring the intestinal barrier in inflammatory diseases

vignete

About Us

We are committed to the development of non-immunosuppressive small molecule therapies for treatment of inflammatory diseases

Our world class team has 2 decades of intestinal epithelial barrier expertise combined with a track record of success spanning over 35 INDs and 6 commercial products

Team

Miro Brajenovic, PhD


Chief Executive Officer

Roman Sakowicz, PhD


Chief Technology Officer, Head of Discovery

Vallen Graham, PhD


Co-founder, Head of Research

Petr Jansa, PhD


Head of Medicinal Chemistry

Nargis Kohgadai


Associate Scientist

Naomi Vinod


Research Associate intern

Scientific Advisory Board

Jerrold Turner, MD, PhD


Co-founder

Bruce Sands, MD


Clinical Advisor

Stefan Schreiber, MD, PhD


Clinical Advisor

Careers

  • Research Associate

  • Senior Research Associate

  • Scientist/Senior Scientist

Contact